STAT3 and cancer: While significant progress has been made with respect to STAT3 inhibitors for cancer applications, more mechanistic data are needed on the role of STAT3 in cancer in order to improve the translation of pre-clinical STAT3 inhibitors to clinically meaningful therapeutics.